Methodology

All entries for: Pasithea Therapeutics Corp.

May 29, 2026

Pasithea Therapeutics Corp.

Orphan Drug Designation

treatment of amyotrophic lateral sclerosis

Disease Area: Rare Diseases
Source
Scroll to Top